Faber Ventures

Faber Ventures

Faber Ventures targets pre-seed and seed-stage deep tech startups across Europe, with an emphasis on teams originating in Southern Europe. The firm structures its investment activity around two primary thematic tracks — applied science and digital transformation, and climate and ocean tech — deploying initial tickets up to €2.5 million per company. Portfolio exposure spans AI-driven agricultural genetics, in-space return logistics, next-generation spacecraft propulsion, enzyme engineering, and plant-based advanced materials. Confirmed positions include Biographica, a crop-genetics AI platform, Atmos Space Cargo, developing orbital return vehicles, ISPTech, building chemical propulsion systems for satellites, and Zymvol, which designs custom industrial enzymes. Faber participates actively in seed rounds, often leading or co-leading transactions alongside a network of Europe-based and international venture firms, including Chalfen Ventures, SOSV, Elaia Partners, and the European Innovation Council. The firm targets a broad European footprint, with named investments in the United Kingdom, Germany, Portugal, and Spain. Its deployment cadence is typified by a focus on commercialising frontier academic research — backing spinouts and technology creators at the earliest institutional stage — rather than later-stage growth or buyout transactions. Faber operates from London and maintains a lean structure defined by a team described as combining entrepreneurial and operating experience. The firm has not publicly disclosed its total assets under management. Its recent activity includes leading the £7 million seed round for Biographica, the first close of Zymvol's €3 million seed, and a $2.5 million seed investment in YPlasma, a company developing solid-state cooling technology for semiconductor applications. These transactions illustrate Faber's recent acceleration in its climate and hard-science verticals. Faber's structural differentiator lies in its tightly scoped, thematic dual-fund approach to pre-seed and seed deep tech investing, targeting a geographic corridor — Southern Europe — where access to highly specialised scientific talent often outpaces the availability of early-stage risk capital. This narrow funnel, combined with a stated advisory network that translates bench science into commercial scale, positions it distinctly from generalist pan-European seed funds.